
Wednesday, November 13, 2024 1:42:57 PM
Abstract title is "Eflapegrastim, a long-acting GCSF, administered the same day as chemotherapy in patients with early-stage breast cancer: Results from a multicenter, open-label, study". Full abstract release date is November 25, 2024.
Recent ASRT News
- Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025 • GlobeNewswire Inc. • 03/20/2025 01:10:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2025 09:14:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2025 08:05:17 PM
- Assertio Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 03/12/2025 08:05:00 PM
- Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 • GlobeNewswire Inc. • 03/05/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:03:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:01:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 11:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:13:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:11:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:09:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 10:01:35 PM
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/03/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 10:00:28 PM
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors • GlobeNewswire Inc. • 12/17/2024 01:30:00 PM
- Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study • GlobeNewswire Inc. • 12/13/2024 01:00:00 PM
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO • GlobeNewswire Inc. • 12/12/2024 01:00:00 PM
- Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer • GlobeNewswire Inc. • 12/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:27:46 PM
- Assertio Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/11/2024 09:02:00 PM
- Assertio Provides Response to Letter from Short-seller • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
4Cable TV International, Inc. To Change Name to Opus Holdings, Inc. Set to Launch New Business Model with Potential Shareholder Dividends and a Fresh Leadership Team • CATV • Mar 25, 2025 8:30 AM
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform • AVAI • Mar 25, 2025 8:00 AM
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant • HLYK • Mar 24, 2025 8:00 AM
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • LFLRF • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM